VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 59 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,512,275 | -27.7% | 582,229 | +6.9% | 0.00% | – |
| Q2 2023 | $6,238,693 | +759.9% | 544,864 | +479.0% | 0.00% | – |
| Q1 2023 | $725,488 | -33.0% | 94,097 | -47.0% | 0.00% | – |
| Q4 2022 | $1,083,324 | +106.0% | 177,594 | +100.0% | 0.00% | – |
| Q3 2022 | $526,000 | +0.2% | 88,797 | 0.0% | 0.00% | – |
| Q2 2022 | $525,000 | -26.3% | 88,797 | -4.9% | 0.00% | – |
| Q1 2022 | $712,000 | +209.6% | 93,397 | +10.1% | 0.00% | – |
| Q4 2021 | $230,000 | +3.1% | 84,814 | 0.0% | 0.00% | – |
| Q3 2021 | $223,000 | -36.3% | 84,814 | 0.0% | 0.00% | – |
| Q2 2021 | $350,000 | -84.8% | 84,814 | -82.7% | 0.00% | – |
| Q1 2021 | $2,310,000 | -41.8% | 490,470 | -11.6% | 0.00% | – |
| Q4 2020 | $3,967,000 | -34.4% | 554,880 | -2.1% | 0.00% | – |
| Q3 2020 | $6,045,000 | -62.6% | 566,559 | -55.8% | 0.00% | -100.0% |
| Q2 2020 | $16,177,000 | +29.1% | 1,281,866 | -6.4% | 0.00% | 0.0% |
| Q1 2020 | $12,532,000 | -32.2% | 1,369,650 | +3.3% | 0.00% | 0.0% |
| Q4 2019 | $18,493,000 | -23.8% | 1,325,648 | -6.0% | 0.00% | -50.0% |
| Q3 2019 | $24,280,000 | -26.2% | 1,410,787 | +16.7% | 0.00% | 0.0% |
| Q2 2019 | $32,895,000 | +354.5% | 1,208,504 | +219.6% | 0.00% | +100.0% |
| Q1 2019 | $7,237,000 | +110.6% | 378,095 | +3.4% | 0.00% | – |
| Q4 2018 | $3,436,000 | -86.1% | 365,555 | -71.9% | 0.00% | -100.0% |
| Q3 2018 | $24,640,000 | +2.5% | 1,302,288 | +5.9% | 0.00% | 0.0% |
| Q2 2018 | $24,037,000 | +60.1% | 1,229,912 | +53.9% | 0.00% | +100.0% |
| Q1 2018 | $15,012,000 | +289.5% | 798,946 | +244.1% | 0.00% | – |
| Q4 2017 | $3,854,000 | -5.7% | 232,160 | +16.9% | 0.00% | – |
| Q3 2017 | $4,089,000 | +147.4% | 198,658 | +7.7% | 0.00% | – |
| Q2 2017 | $1,653,000 | -24.3% | 184,526 | +11.8% | 0.00% | – |
| Q1 2017 | $2,185,000 | +3.7% | 165,055 | -0.3% | 0.00% | – |
| Q4 2016 | $2,108,000 | +11.6% | 165,503 | +5.3% | 0.00% | – |
| Q3 2016 | $1,889,000 | +20.7% | 157,246 | +10.3% | 0.00% | – |
| Q2 2016 | $1,565,000 | +211.8% | 142,611 | +147.1% | 0.00% | – |
| Q1 2016 | $502,000 | -50.0% | 57,705 | +26.0% | 0.00% | – |
| Q4 2015 | $1,003,000 | – | 45,805 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |